With childhood obesity, diabetes and other endocrine disorders on the rise, we use a team approach to give children the best possible care. Our distinguished team includes UT Southwestern physicians practicing at Children's Health, as well as dietitians, psychologists and social workers, all working together to deliver therapies and support for everything from diabetes to obesity to gender-affirming care.
And, as one of the nation’s busiest endocrinology teams – we log more than 18,000 outpatient visits and 700 inpatient admissions a year – we have the expertise to match each patient with the treatment that’s right for them.
A monoclonal antibody called Tzield gives children with Stage 2 type 1 diabetes the chance to delay the onset of symptoms and the need for insulin therapy. Learn why Tzield is a game-changer and what to know about screening and other details. Read more »
Learn how cutting-edge treatments help improve the quality of life for children with metabolic bone diseases. Read more »
In a recent pilot trial, researchers at Children’s Health and UT Southwestern discovered that an FDA-approved weight loss drug called orlistat reduced blood triglyceride levels by more than 50% in T1HLP patients. Now the researchers are planning a larger trial to study orlistat’s long-term efficacy and safety in children and adults. Read more »